Immuneering (IMRX) Accumulated Expenses (2020 - 2026)
Immuneering's Accumulated Expenses was $7.5 million in Q3 2026, up 0.2% from $7.48 million a year earlier and up 83.1% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Immuneering came in at $7.84 million, up 57.7% from FY2024.
- Accumulated Expenses shows a five-year compound annual growth rate of 62.2% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $4.97 million in FY2024 (-3.9%), $5.17 million in FY2023 (+15.0%), $4.5 million in FY2022 (+13.5%) and $3.97 million in FY2021 (+467.3%).
- Quarterly Accumulated Expenses has moved between $1.72 million (Q1 2022) and $7.84 million (Q4 2025) over five years.
- Compared with a year earlier, Accumulated Expenses was higher in five of the last eight quarters, with growth averaging 18.7%.
- The best year-over-year quarter for Accumulated Expenses over five years was Q4 2021 (growth of 467.3%); the worst was Q2 2022 (a decline of 32.9%).
- Per Business Quant data, IMRX's Accumulated Expenses in the three quarters before Q3 2026 was $4.09 million (Q2 2026), $3.06 million (Q1 2026) and $7.84 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Immuneering | 249.34 Mn | -375.49 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.50 Mn |
| Jun 30, 2026 | 4.09 Mn |
| Mar 31, 2026 | 3.06 Mn |
| Dec 31, 2025 | 7.84 Mn |
| Sep 30, 2025 | 7.48 Mn |
| Jun 30, 2025 | 4.51 Mn |
| Mar 31, 2025 | 3.39 Mn |
| Dec 31, 2024 | 4.97 Mn |
| Sep 30, 2024 | 4.59 Mn |
| Jun 30, 2024 | 3.76 Mn |
| Mar 31, 2024 | 2.58 Mn |
| Dec 31, 2023 | 5.17 Mn |
| Sep 30, 2023 | 3.30 Mn |
| Jun 30, 2023 | 2.43 Mn |
| Mar 31, 2023 | 2.41 Mn |
| Dec 31, 2022 | 4.50 Mn |
| Sep 30, 2022 | 4.56 Mn |
| Jun 30, 2022 | 2.23 Mn |
| Mar 31, 2022 | 1.72 Mn |
| Dec 31, 2021 | 3.97 Mn |
API Access
Immuneering Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();